Back to Search
Start Over
Vanda Pharmaceuticals announces the publication of Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study in the Journal of Clinical Psychiatry
- Source :
- PR Newswire. January 17, 2024
- Publication Year :
- 2024
-
Abstract
- WASHINGTON, Jan. 17, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article titled 'Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.779625469